Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The venous vascular smooth muscle contractile machinery is a complex physiological system comprising the proteins and signaling pathways that regulate the contraction and relaxation of smooth muscle cells within the venous walls. The core of this machinery is the actomyosin complex, where the interaction between actin and myosin filaments generates the force necessary to maintain venous tone and facilitate blood return to the heart (IntechOpen, 2015). This process is primarily controlled by the phosphorylation of the 20-kDa regulatory myosin light chain (MLC20), a reaction catalyzed by myosin light chain kinase (MLCK) in response to increased intracellular calcium and inhibited by myosin light chain phosphatase (MLCP) (NIH, 2018). The machinery also includes regulatory proteins such as caldesmon and calponin which modulate the actin-myosin interaction, as well as signaling components like Rho-kinase that provide calcium-independent mechanisms for sustaining tone (NIH, 2001; MDPI, 2021). In conditions such as chronic venous insufficiency and varicose veins, the machinery's ability to maintain adequate tension is compromised, leading to venous stasis and hypertension (MDPI, 2021). Therapeutic agents known as phlebotonics or venotonics, including diosmin and escin, target this machinery by enhancing calcium sensitivity or prolonging adrenergic signaling to restore venous wall integrity and improve hemodynamics (NIH, 2015). Consequently, this system serves as a vital target for managing peripheral vascular diseases and ensuring efficient circulatory function.
Modulation of the phosphorylation state of myosin light chains through calcium-dependent and calcium-sensitizing pathways to regulate actin-myosin cross-bridge formation and venous wall tension.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venous vascular smooth muscle contractile machinery (VVSM contractile machinery).